540359
PARMAX
Start SIP
Invest Now
Start SIP in PARMAX
Performance
- Low
- ₹31
- High
- ₹32
- 52 Week Low
- ₹28
- 52 Week High
- ₹55
- Open Price₹32
- Previous Close₹32
- Volume4,777
- 50 DMA₹33.66
- 100 DMA₹34.13
- 200 DMA₹35.63
Investment Returns
- Over 1 Month -11.85%
- Over 3 Month 0%
- Over 6 Month -16.97%
- Over 1 Year -22.08%
Smart Investing Starts Here Start SIP with Parmax Pharma for Steady Growth!
Parmax Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -2.4
- PEG Ratio
- 0
- Market Cap Cr
- 12
- P/B Ratio
- -2.2
- Average True Range
- 3.33
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.16
- RSI
- 45.51
- MFI
- 67.55
Parmax Pharma Financials
Parmax Pharma Technicals
EMA & SMA
Current Price
₹32.00
0
(0%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹33.51
- 50 Day
- ₹33.66
- 100 Day
- ₹34.13
- 200 Day
- ₹35.63
Resistance and Support
31.86
- R3 32.82
- R2 32.45
- R1 32.23
- S1 31.64
- S2 31.27
- S3 31.05
Parmax Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-14 | Quarterly Results |
Parmax Pharma F&O
About Parmax Pharma
- NSE Symbol
- PARMAX
- BSE Symbol
- 540359
- Managing Director
- Dr. Umang Alkesh Gosalia
- ISIN
- INE240T01014
Similar Stocks to Parmax Pharma
Parmax Pharma FAQs
Parmax Pharma share price is ₹32 As on 16 February, 2026 | 17:37
The Market Cap of Parmax Pharma is ₹12 Cr As on 16 February, 2026 | 17:37
The P/E ratio of Parmax Pharma is -2.4 As on 16 February, 2026 | 17:37
The PB ratio of Parmax Pharma is -2.2 As on 16 February, 2026 | 17:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.